Lisinopril

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lisinopril

What is Lisinopril?

Lisinopril is a pharmaceutical medication belonging to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily utilized in the management of cardiovascular conditions, specifically hypertension and certain types of heart failure.

Mechanism of Action

The medication functions by inhibiting the ACE enzyme, which plays a key role in the body's renin-angiotensin-aldosterone system. By blocking this enzyme, the production of angiotensin II—a potent substance that causes blood vessels to narrow—is reduced. The decrease in angiotensin II levels leads to the relaxation and widening of blood vessels, which facilitates easier blood flow and lowers overall blood pressure.

Additionally, the reduction of angiotensin II decreases the secretion of aldosterone, a hormone involved in sodium and water retention. This combined effect helps to decrease the workload on the heart and improve circulatory efficiency.

Clinical Applications

Lisinopril is frequently indicated for the following therapeutic purposes:

  • Hypertension: It is used to manage high blood pressure, helping to maintain levels within a target range to reduce the long-term strain on the cardiovascular system.
  • Heart Failure: It is employed as part of a management strategy for heart failure, where it helps improve the heart's pumping ability and manages symptoms.
  • Post-Myocardial Infarction: It may be administered following a heart attack to improve survival rates and reduce the risk of developing further heart failure.

As a systemic treatment, lisinopril is typically administered orally and requires consistent use as directed by a healthcare professional to achieve its intended physiological effects.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Lisinopril?

Possible Side Effects and Safety Information

The safety profile of lisinopril, an Angiotensin-Converting Enzyme (ACE) inhibitor, is officially documented by government health authorities to ensure clear communication of potential risks. Adverse reactions are grouped by frequency and the physiological system affected.


Frequency and System-Organ Classifications

Adverse reactions are classified into frequency tiers and related to specific organ systems as per regulatory standards. Common reactions include headache, dizziness, and a persistent, dry cough (a known class effect). Hypotension (low blood pressure) is also classified as common, particularly at the start of treatment or during dose adjustments. Uncommon events include gastrointestinal issues like diarrhea and nausea, as well as skin reactions such as rash. Rare events include acute renal failure and urticaria.


Serious Adverse Reactions and Safety Constraints

The most serious documented risk is Angioedema, a rapid, potentially life-threatening swelling of the face, tongue, and throat, which can occur at any time during treatment. Lisinopril also carries an explicit regulatory Boxed Warning concerning Fetal Toxicity, stating that use during the second and third trimesters of pregnancy can cause injury or death to the developing fetus, requiring discontinuation if pregnancy is detected. Safety constraints prohibit its use in individuals with a history of Angioedema related to prior ACE inhibitor treatment. Furthermore, patients with renal impairment or those who are volume-depleted are noted to be at higher risk for symptomatic hypotension, necessitating careful monitoring of renal function and serum potassium.

Overdose and Emergency Response

Overdose and When to Seek Help

Lisinopril, like all medications, carries a risk of overdose if taken in quantities exceeding the prescribed dosage. The most prominent and critical effect of a Lisinopril overdose is severe hypotension (extremely low blood pressure). This is an extension of the drug’s primary therapeutic action.

Common signs of overdose may include:

  • Extreme dizziness or lightheadedness
  • Fainting (syncope)
  • Profound weakness

In more severe, though rare, cases, a significant drop in blood pressure can lead to symptoms of shock, kidney injury, or a very slow heartbeat (bradycardia). An overdose, especially in individuals with pre-existing heart or kidney conditions, requires immediate medical attention.

When to Seek Emergency Help

If you or someone else is suspected of having taken more than the prescribed dose of Lisinopril, immediately call local emergency services or a poison control center, even if no symptoms are present. Do not wait for symptoms to appear.

Seek immediate, emergency medical care if the individual exhibits any of the following signs, which may indicate dangerously low blood pressure or an allergic reaction:

  • Loss of consciousness or difficulty waking up
  • Difficulty breathing or swallowing
  • Severe swelling of the face, lips, tongue, or throat (angioedema)
  • Chest pain or tightness

Therapeutic Uses of Lisinopril

Lisinopril is a common therapeutic option for managing conditions marked by increased physiological stress from chronic pressure and cardiovascular load. It is used in the treatment of high blood pressure, heart failure, and for support after a heart attack.

Managing Chronic High Blood Pressure

This domain addresses Essential Hypertension, a condition characterized by periods of heightened symptoms where blood pressure is consistently too high. Lisinopril is commonly used to achieve sustained blood pressure lowering, which may assist in easing the physiological strain on the cardiovascular system. The main therapeutic use is applied across key cardiovascular conditions, including chronic high blood pressure, symptomatic heart failure, and when supportive symptom management is appropriate following a heart attack. This action may help reduce the risk of future cardiovascular complications.

“Lisinopril is applied in situations requiring long-term symptomatic support to maintain functional stability against the effects of chronic high pressure.”

Supporting Heart Function and Stability

Lisinopril is commonly used in treatment plans for Heart Failure and is considered relevant when supportive symptom management is appropriate following an Acute Myocardial Infarction. It helps address symptom clusters of fluid and pressure overload, providing therapeutic support that helps ease the workload on the heart. This action may assist with maintaining functional stability and contributes to easing the overall symptom load. Additionally, for patients with Diabetes Mellitus showing early kidney involvement, Lisinopril may assist in managing symptoms related to kidney involvement over time.


Quick Fact: Relief for Symptoms That Create Noticeable Physiological Strain Lisinopril is relevant for easing symptoms that create noticeable physiological strain in chronic cardiovascular conditions, and may contribute to maintaining functional stability and easing the overall systemic burden.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Lisinopril? Official Eligibility Rules

Lisinopril eligibility is strictly defined by regulatory documents, distinguishing between approved use, contraindications, and restricted use populations.

Contraindicated Populations

Lisinopril is absolutely contraindicated in patients with a history of angioedema related to prior use of any Angiotensin-Converting Enzyme (ACE) inhibitor, or patients with hereditary or idiopathic angioedema. It is also prohibited for women in the second and third trimesters of pregnancy due to risk of fetal harm. Use is forbidden in patients with Diabetes Mellitus who are simultaneously receiving medication containing Aliskiren.

Age-Related and Restricted Use

The medicine is approved for adults for all labeled uses. In the pediatric population, use is not recommended for children under six years of age as safety and efficacy are not established. For adults with severe renal impairment (creatinine clearance <30 mL/min), eligibility is conditional and requires a reduced initial dose. Use is also not recommended during the first trimester of pregnancy or while breastfeeding.

What should I know about interactions with other medicines?

Lisinopril Interactions with Other Medicines and Products

The interaction profile of Lisinopril is defined by specific combinations that pose risks due to additive effects on blood pressure, electrolyte levels, or angioedema risk, as officially documented by regulatory authorities.

Formally Contraindicated Combinations

Co-administration is formally prohibited in certain circumstances due to the high risk of severe adverse reactions:

  • Neprilysin Inhibitors (e.g., Sacubitril/Valsartan): This combination is contraindicated due to a significantly increased risk of angioedema. A minimum 36-hour separation period is required between the last dose of a Neprilysin Inhibitor and the initiation of Lisinopril.
  • Aliskiren: Co-administration is contraindicated in patients with diabetes mellitus due to the increased risk of decreased renal function and hyperkalemia.

Pharmacodynamic Interactions

Interactions primarily result from combined effects on the body's systems, requiring caution and monitoring:

  • Diuretics and Potassium-Elevating Agents: Concomitant use with potassium supplements or potassium-sparing diuretics (e.g., Spironolactone) significantly increases the risk of hyperkalemia (high serum potassium).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Use may attenuate Lisinopril’s blood pressure-lowering effect and increase the risk of worsening renal function.
  • Lithium: Lisinopril reduces the renal clearance of Lithium, leading to increased serum concentrations and potential toxicity.
  • mTOR Inhibitors: Co-administration is associated with an increased risk of angioedema.

Other Documented Interactions

Lisinopril is primarily excreted unchanged by the kidneys; therefore, no major metabolic (CYP) interactions are documented. Its absorption is not officially affected by food. However, alcohol may have an additive effect in lowering blood pressure.

Mechanism of Action

Lisinopril functions as a competitive inhibitor of Angiotensin-Converting Enzyme (ACE), primarily within the vascular endothelium. ACE is a zinc-containing metalloprotease responsible for catalyzing the conversion of the inactive decapeptide angiotensin I to the octapeptide angiotensin II. By binding to the active site of ACE, lisinopril prevents this catalytic action.

The resulting reduction in circulating and local concentrations of angiotensin II diminishes its biological activity. Angiotensin II is a primary effector molecule in the Renin-Angiotensin-Aldosterone System (RAAS), mediating potent vasoconstriction and stimulating the synthesis and release of aldosterone from the adrenal cortex.

Consequently, the inhibition of ACE leads to two major physiological consequences: vasodilation due to the reduced action of angiotensin II on AT1 receptors in vascular smooth muscle, and a decrease in aldosterone-mediated sodium and water reabsorption in the kidney. These actions modulate systemic vascular tone and fluid balance.

Dosage and Administration Information

Administration Guidelines for Lisinopril

Lisinopril is administered by the oral route using tablets or, for precise dose measurement, an oral solution (typically 1 mg/mL). The administration frequency for approved uses is once daily. The medication can be taken with or without food, but administration at the same time each day is recommended to establish a consistent schedule.


Administration Scope

Usage Entity Instruction Detail
Dosing Schedule Initial adult doses are generally 10 mg for hypertension and 5 mg for heart failure, increasing to a usual maximum of 40 mg once daily. A specific step-up regimen of 5 mg, 5 mg, then 10 mg is used for patients after acute myocardial infarction (MI).
Renal Adjustment For adults with impaired kidney function (creatinine clearance leq 30 mL/min), the initial dose is typically halved (e.g., 5 mg for hypertension) or started at a low fixed dose of 2.5 mg for severe impairment or dialysis patients.
Pediatric Rules For children 6 years with adequate kidney function, dosing is weight-based (starting at 0.07 mg/kg daily, maximum initial dose 5 mg).
Missed Dose If a dose is missed, it should be taken as soon as remembered; however, if it is almost time for the next scheduled dose, the missed dose should be skipped. Double doses should never be taken.
Duration The use is long-term for chronic conditions, but for post-MI management, treatment is generally continued for a minimum of six weeks.

Recent Clinical Evidence

Research Evidence for Lisinopril


Evidence for Use in Managing Chronic High Blood Pressure

Research has explored lisinopril in Randomized Controlled Trials (RCTs) and active-controlled clinical trials. These studies examined outcomes related to systemic or functional imbalance. Populations included adults with high blood pressure, and dedicated studies examined pediatric patients (children aged 6 to 16) and older patients (65 and over).

Studies report measurements of both systolic and diastolic blood pressure, describing the patterns observed in the data across the study periods. Research describes patterns showing that the average change in blood pressure was observed in some studies to be smaller in Black hypertensive patients compared to non-Black patients.


Evidence for Use in Chronic Heart Failure

Lisinopril was studied for chronic heart failure in major, long-term RCTs. These large studies examined outcomes monitoring physiological strain or stress. Researchers monitored outcomes describing episodic or acute changes, particularly all-cause mortality and the frequency of hospitalization, in adult patients with reduced heart function.

Major long-term trials reported measurements of survival rates and hospitalization frequency over follow-up durations that often spanned several years. Findings were mixed in some large trials that explored different dosage strategies, where the difference in the specific outcome of all-cause mortality between higher and lower doses was not statistically distinguished.


Evidence for Use Following an Acute Myocardial Infarction

Research examined lisinopril in large, multi-center RCTs following an acute heart attack. Lisinopril was observed in adult patients soon after the acute event, specifically when treatment was initiated within 24 hours of symptoms. Studies monitored outcomes related to physical discomfort, such as mortality rates and the development of markers for left ventricular dysfunction.

Studies report how symptoms evolved in the observed populations by providing insight into short-term changes in mortality and dysfunction over intermediate follow-up durations. Study results reflect the specific conditions under which they were conducted, meaning they primarily apply to patients who were hemodynamically stable at the time treatment started.

Key Studies & References

  1. World Health Organization Model List of Essential Medicines
  2. NIH MedlinePlus Overview: Lisinopril Indications and Use

Frequently Asked Questions (FAQ)

Common questions about Lisinopril (FAQ)

Q: How long does it typically take for Lisinopril to start working for blood pressure?

A: According to official product information, the effect of lisinopril on blood pressure begins within approximately two hours after a dose is taken. The concentration of the medication in the blood generally reaches its peak around seven hours after administration.

Q: Does Lisinopril affect sexual function in men or women?

A: Regulatory documents indicate that sexual function-related side effects have been reported. Specifically, impotence (the inability to have or maintain an erection) has been reported as an uncommon adverse event associated with lisinopril use.

Q: Can Lisinopril cause weight gain or weight loss?

A: Lisinopril has been associated with edema (fluid retention or swelling) in some cases, which can sometimes result in the appearance of weight changes. Weight gain is also a symptom that can be associated with the underlying conditions lisinopril is used to manage.

Q: Is Lisinopril used to prevent strokes?

A: Lisinopril is officially indicated for the treatment of hypertension (high blood pressure) and heart failure. Managing and lowering high blood pressure is a key part of reducing the overall risk of cardiovascular events, which include stroke.

Q: Can seasonal allergies or cold medicines interfere with Lisinopril?

A: Interactions between lisinopril and certain components often found in cold or allergy medicines, such as some decongestants or antihistamines, may be possible. Patients are generally advised to discuss all over-the-counter medications or supplements with a healthcare provider before use.

Q: Can Lisinopril cause my heart rate to change?

A: Official labeling reports that changes in heart rate are possible, though they are uncommon. Side effects such as palpitations or a fast or irregular heartbeat (tachycardia) have been reported with the use of lisinopril.

Q: Is it normal to feel a tingling sensation when starting Lisinopril?

A: Paresthesias (abnormal sensations such as tingling, numbness, or prickling) have been reported as an uncommon side effect. If these sensations are experienced, it is generally recommended to note them and discuss them with a healthcare provider.

Q: Why do some people take Lisinopril in the morning and others in the evening?

A: Lisinopril is generally intended to be taken once daily. While the medication can be taken with or without food, regulatory guidance recommends administering it at the same time each day to maintain a consistent dosing schedule.

Q: Can Lisinopril cause changes in my sense of taste?

A: Yes, official adverse reaction reports include taste disturbance (known medically as dysgeusia). This is a reported side effect of the medication.

Q: Do researchers look at Lisinopril for uses outside of heart and kidney conditions?

A: The approved uses for lisinopril focus on hypertension, heart failure, and post-myocardial infarction (MI) management. However, as is common with many established medicines, research may explore uses for lisinopril in other conditions that are not currently approved by regulatory bodies.

Q: Can Lisinopril be taken if I have asthma or other breathing issues?

A: Lisinopril is associated with a common side effect of a persistent dry cough. Additionally, rare side effects affecting the respiratory system, such as inflammation of the lungs or sudden narrowing of the airways (bronchospasm), have been documented in official safety information.

Q: Can Lisinopril cause me to feel dizzy or tired?

A: Yes, official labeling lists feeling dizzy as a common side effect. Unusual tiredness or weakness (often referred to as asthenia or fatigue) is also a reported side effect of lisinopril.

Q: Is it safe to drink alcohol while taking Lisinopril?

A: Official regulatory information notes that alcohol may have an additive effect in lowering blood pressure when combined with lisinopril. This combination may increase the risk of symptoms like lightheadedness or fainting.

Q: Does Lisinopril interact with common supplements like potassium or magnesium?

A: It is officially recommended that lisinopril not be used with potassium supplements or salt substitutes containing potassium, as this significantly increases the risk of high serum potassium (hyperkalemia). Information on specific interactions with magnesium is not detailed in the product labeling.

Q: Is there any research about Lisinopril's long-term effects on kidney function?

A: Regulatory warnings indicate that lisinopril carries a risk of potentially decreasing renal function, especially in patients with pre-existing kidney impairment. The medication itself is primarily eliminated from the body by the kidneys, and monitoring of kidney function is often necessary.

Q: Is Lisinopril safe to use if I have diabetes?

A: Lisinopril is contraindicated (prohibited) for use in patients with diabetes if they are simultaneously receiving a medication containing the ingredient Aliskiren. Excluding this specific combination, the decision regarding eligibility for diabetic patients is based on the prescribing information and a healthcare assessment.

Q: Are there specific foods I should avoid while on Lisinopril?

A: Official warnings recommend avoiding high dietary intake of potassium, as well as any salt substitutes that contain potassium. This precaution is necessary due to the risk of developing dangerously high potassium levels while taking the medicine.

Q: What is the connection between Lisinopril and kidney protection?

A: Lisinopril is an ACE inhibitor that helps to lower blood pressure and also reduces aldosterone, which lessens the retention of salt and water by the kidneys. Official sources describe lisinopril’s use in managing kidney conditions in certain people with diabetes mellitus.

Q: Can Lisinopril affect my ability to drive or operate machinery?

A: Dizziness and lightheadedness are common side effects that can occur, especially when starting treatment or adjusting the dose. Official guidance advises caution about driving or operating hazardous machinery until you understand how the medication affects your body.

Q: Can high heat or exercise affect someone taking Lisinopril?

A: Patients who are volume-depleted or dehydrated are noted to be at a higher risk of symptomatic low blood pressure (hypotension). Excessive sweating from strenuous exercise or exposure to high heat can lead to volume depletion, potentially worsening this risk.

Q: Is Lisinopril often taken with a diuretic?

A: Lisinopril is available as a single active ingredient product. However, it is also commonly studied and used in combination with diuretics to enhance the blood pressure-lowering effect, and official warnings exist regarding co-administration with potassium-sparing diuretics.

Q: What kind of monitoring (like blood tests) is commonly needed while taking Lisinopril?

A: Regulatory documents indicate that monitoring of kidney function and serum potassium levels is necessary. This monitoring is particularly important when beginning treatment or changing the dose, as lisinopril can impact both systems.

Q: How quickly do the side effects of Lisinopril usually appear?

A: Low blood pressure (hypotension) is most likely to be observed at the very beginning of treatment or when the dose is changed. Conversely, a serious reaction like Angioedema (swelling) can occur at any time during the therapy.

Q: Are there specific symptoms that warrant calling a doctor immediately after starting Lisinopril?

A: Yes, any symptoms suggestive of Angioedema should be reported immediately. These include swelling of the face, extremities, eyes, lips, or tongue, or any difficulty swallowing or breathing.

How should Lisinopril be stored and disposed of?

How to Store and Dispose of Lisinopril?

Lisinopril tablets must be stored at Controlled Room Temperature (CRT), which is 20 C to 25 C (68 F to 77 F). The regulatory requirements for storage and handling ensure the medication's stability and integrity.

Storage Requirements

Requirement Official Instruction
Temperature Range 20 C to 25 C
Environmental Protection Protect from moisture, freezing, and excessive heat
Container Rule Dispense and keep in a tight container
Child Safety Store out of the reach of children

Disposal

Unused or expired Lisinopril and related waste materials must be disposed of in accordance with local requirements for pharmaceutical products. Disposal procedures must prevent the medication from entering water sources.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lisinopril found in:

A-Z Index: